Financials data is unavailable for this security.
View more
Year on year GuangYuYuan Chinese Herbal Medicine Co Ltd grew revenues 13.56% from 1.13bn to 1.28bn while net income improved from a loss of 250.02m to a gain of 90.08m.
| Gross margin | 72.86% |
|---|---|
| Net profit margin | 11.91% |
| Operating margin | 13.62% |
| Return on assets | 6.01% |
|---|---|
| Return on equity | 8.54% |
| Return on investment | 8.95% |
More ▼
Cash flow in CNYView more
In 2023, GuangYuYuan Chinese Herbal Medicine Co Ltd increased its cash reserves by 5.33%, or 13.00m. The company earned 215.50m from its operations for a Cash Flow Margin of 16.78%. In addition the company used 1.19m on investing activities and also paid 201.31m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 3.18 |
|---|---|
| Tangible book value per share | 2.99 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.00 |
|---|---|
| Quick ratio | 1.05 |
| Total debt/total equity | 0.0643 |
|---|---|
| Total debt/total capital | 0.0597 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items increased 136.03%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| EPS growth(5 years) | -24.64 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 167.96 |
